Oregon Public Employees Retirement Fund’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $719K | Buy |
9,592
+100
| +1% | +$6.42K | 0.01% | 1094 |
|
|
2026
Q1 | $535K | Buy |
9,492
+100
| +1% | +$6.51K | 0.01% | 1147 |
|
|
2025
Q4 | $753K | Sell |
9,392
-300
| -3% | -$20.2K | 0.01% | 990 |
|
|
2025
Q3 | $472K | Sell |
9,692
-600
| -6% | -$37.1K | 0.01% | 1166 |
|
|
2025
Q2 | $768K | Hold |
10,292
| – | – | 0.01% | 916 |
|
|
2025
Q1 | $654K | Buy |
10,292
+100
| +1% | +$6.8K | 0.01% | 998 |
|
|
2024
Q4 | $796K | Sell |
10,192
-200
| -2% | -$16.1K | 0.01% | 921 |
|
|
2024
Q3 | $835K | Sell |
10,392
-200
| -2% | -$16.2K | 0.02% | 904 |
|
|
2024
Q2 | $876K | Sell |
10,592
-1,961
| -16% | -$173K | 0.02% | 823 |
|
|
2024
Q1 | $1.07M | Sell |
12,553
-1,769
| -12% | -$139K | 0.02% | 786 |
|
|
2023
Q4 | $1.22M | Buy |
14,322
+100
| +0.7% | +$8.64K | 0.02% | 775 |
|
|
2023
Q3 | $1.27M | Sell |
14,222
-400
| -3% | -$35.7K | 0.02% | 812 |
|
|
2023
Q2 | $1.24M | Sell |
14,622
-100
| -0.7% | -$8.46K | 0.01% | 872 |
|
|
2023
Q1 | $1.22M | Sell |
14,722
-175
| -1% | -$14.2K | 0.02% | 873 |
|
|
2022
Q4 | $1.17M | Sell |
14,897
-89
| -0.6% | -$7.15K | 0.02% | 886 |
|
|
2022
Q3 | $1.11M | Buy |
14,986
+89
| +0.6% | +$6.39K | 0.02% | 860 |
|
|
2022
Q2 | $971K | Sell |
14,897
-1,500
| -9% | -$88.8K | 0.01% | 821 |
|
|
2022
Q1 | $1.04M | Sell |
16,397
-184
| -1% | -$10K | 0.01% | 1068 |
|
|
2021
Q4 | $879K | Sell |
16,581
-500
| -3% | -$30.5K | 0.01% | 1076 |
|
|
2021
Q3 | $1.21M | Sell |
17,081
-225
| -1% | -$14.2K | 0.01% | 890 |
|
|
2021
Q2 | $1.15M | Buy |
17,306
+428
| +3% | +$30.3K | 0.01% | 935 |
|
|
2021
Q1 | $1.87M | Buy |
16,878
+110
| +0.7% | +$13.6K | 0.02% | 615 |
|
|
2020
Q4 | $1.99M | Sell |
16,768
-338
| -2% | -$36.4K | 0.03% | 544 |
|
|
2020
Q3 | $1.49M | Sell |
17,106
-1,788
| -9% | -$156K | 0.02% | 589 |
|
|
2020
Q2 | $1.69M | Sell |
18,894
-209
| -1% | -$21.1K | 0.03% | 545 |
|
|
2020
Q1 | $1.9M | Sell |
19,103
-140
| -0.7% | -$15.2K | 0.03% | 448 |
|
|
2019
Q4 | $2.21M | Sell |
19,243
-1,785
| -8% | -$216K | 0.03% | 528 |
|
|
2019
Q3 | $2.65M | Buy |
21,028
+405
| +2% | +$51.4K | 0.03% | 510 |
|
|
2019
Q2 | $2.48M | Buy |
20,623
+34
| +0.2% | +$3.35K | 0.03% | 526 |
|
|
2019
Q1 | $1.8M | Hold |
20,589
| – | – | 0.03% | 635 |
|
|
2018
Q4 | $2.06M | Buy |
20,589
+7,041
| +52% | +$740K | 0.03% | 528 |
|
|
2018
Q3 | $1.55M | Buy |
13,548
+13,258
| +4,572% | +$1.37M | 0.02% | 766 |
|
|
2018
Q2 | $26K | Buy |
+290
| New | +$24.5K | ﹤0.01% | 1090 |
|
Other funds holding HAE
Oregon Public Employees Retirement Fund's HAE Position: Q2 2026 in Review
Oregon Public Employees Retirement Fund increased its Haemonetics (HAE) stake by 1.1% in Q2 2026, buying an estimated $6.42K and bringing the position to 9,592 shares worth $719K. The position accounts for 0.01% of the portfolio, ranked #1094.
Oregon Public Employees Retirement Fund first reported a position in HAE in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.65M in Q3 2019. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Oregon Public Employees Retirement Fund held 9,592 shares of Haemonetics worth $719K as of Q2 2026.
- Oregon Public Employees Retirement Fund bought 100 Haemonetics shares in Q2 2026, an estimated $6.42K.
- Haemonetics made up 0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1094 holding.
- Oregon Public Employees Retirement Fund first reported a position in Haemonetics in Q2 2018 and has held it in 33 quarters since.
- Oregon Public Employees Retirement Fund's Haemonetics position peaked at $2.65M in Q3 2019.
- 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.